We investigated the effects of lauroylcarnitine and palmitoylcarnitine on major tight junction proteins such as claudins in Caco-2 cell monolayers and also examined the involvement of cholesterol in the effects induced by both acylcarnitines on these proteins. We investigated the effects of lauroylcarnitine and palmitoylcarnitine on the barrier function of tight junctions by measuring transepithelial electrical resistance (TEER) and fluorescein isothiocyanate dextran 40,000 (FD-40) flux. A decrease in the TEER value and an increase in FD-40 flux were observed after incubating Caco-2 cell monolayers with lauroylcarnitine and palmitoylcarnitine for 1 h, suggesting the loss of the barrier function of tight junctions. In addition, lauroylcarnitine and palmitoylcarnitine decreased the protein levels of claudin 1, 4, and 5 but not those of claudin 2, 3, 6, or 7. In addition, palmitoylcarnitine and methyl-¢-cyclodextrin increased cholesterol release from the plasma membrane. It is suggested that the effects of palmitoylcarnitine and methyl-¢-cyclodextrin on claudin 4 and 5 may be associated with cholesterol leakage from the plasma membrane into the apical side. These results indicate that the protein levels of claudin 4 and 5 are decreased by treatment with palmitoylcarnitine and lauroylcarnitine, and that this change is involved in the absorption-enhancing mechanism.
Introduction
Tight junctions play a central role in sealing the lateral intercellular space between the apical and basolateral compartments of epithelial and endothelial cells. The structure of tight junctions is a complex involving transmembrane and peripheral proteins. The transmembrane proteins form tight junction strands, which play a crucial role in the barrier function. During the 1980s and 1990s, the transmembrane proteins occludin 1¥ and claudin 2¥ and the peripheral proteins ZO-1, 3¥ ZO-2, 4¥ and cingulin 5¥ were discovered. Claudin and occludin were assumed to form tight junction strands and therefore to be the main components involved in the barrier function. At first, occludin was believed to be responsible for the barrier function since its overexpression improved barrier function. 6¥ However, when it became clear that claudin alone is sufficient for the formation of tight junction strands, 1¥ a consensus was formed that claudin is the most important component of the barrier function. To date, 24 claudin subtypes have been identified, 7,8¥ and their expression levels demonstrate tissue-specific variations in resistance and ion selectivity. 9®11¥ For example, mice deficient in claudin 1 and 5 lose barrier function in the epidermis and the blood®brain barrier, respectively. 12,13¥ Furthermore, the COOH-terminal half fragment of Clostridium perfringens enterotoxin ¤C-CPE¥ binds to claudin 4 and exerts an absorption-enhancing effect on the rat digestive tract, 14¥ suggesting that claudin 4 is the major barrier factor in the digestive tract. In addition, cells that overexpress claudin 2 or claudin 4 show altered ion selectivity.
15,16¥ Taken together, these observations suggest that the tissue specificity of claudins is crucial for the diversity of barrier function.
Numerous investigations have attempted to modulate the barrier function of the tight junctions in order to enhance hydrophilic drug absorption in the intestine. To date, the sodium salts of several medium chain fatty acids, particularly sodium caprate, are the only compounds that have successfully enhanced drug absorption, and these have been applied in the clinical setting as intestinal absorption enhancers. The action mechanisms of these salts are proposed to involve an intracellular signal transduction pathway triggered by the activation of myosin light chain kinase 17,18¥ and phospholipase C 19¥ on plasma membranes. Very recently, Sugibayashi et al. demonstrated that claudin 4 and 5 and occludin were displaced from lipid rafts after treatment with sodium caprate and suggested the involvement of this displacement in the absorption-enhancing mechanism of sodium caprate. 20¥ It is proposed that such tight junction complexes are associated with cholesterol-rich plasma membrane úlipid raftsû. 21¥ Lipid rafts consist of cholesterol and sphingomyelin and form a tightly packed region. Lipid rafts are considered to be a platform for signal transduction since many signaling molecules such as G proteins and kinases are localized in them. The localization of proteins in lipid rafts has led to the idea that lipid rafts regulate the functions of proteins. One means to test this notion is to examine the alterations in protein function and distribution that occur when lipid rafts are disrupted. Methyl-Ç-cyclodextrin ¤methyl-Ç-CD¥ withdraws cholesterol, a main component of lipid rafts, from the plasma membrane, and thus is known as a lipid raft disrupter.
22¥
Acylcarnitines have unique structures as zwitterionic surfactants as shown in Scheme 1. The critical micelle concentration values are 1.20 mM and 0.075 mM for lauroylcarnitine and palmitoylcarnitine, respectively. Acylcarnitines perturb the rat jejunum and decrease membrane resistance in the rat colon and Caco-2 cell monolayers 23®27¥ in the same manner as sodium caprate. It is considered that acylcarnitines probably open intestinal tight junctions by affecting certain claudin subtypes, but little is known about the effects of acylcarnitines on tight junction proteins. In the present study, we focused on the detailed mechanism of the effects of acylcarnitines on tight junction proteins, including particular claudin subtypes, and on cholesterol in Caco-2 cell monolayers. We hypothesized from the effect of methyl-Ç-CD that the opening of tight junctions requires the displacement of major tight junction proteins. Our purpose is to clarify the effects of acylcarnitines on cholesterol and on major tight junction proteins.
Materials and Methods
Materials: Lauroylcarnitine, palmitoylcarnitine, methyl-Ç-cyclodextrin ¤methyl-Ç-CD¥, tetraethylammonium ¤TEA¥, sodium azide, and fluorescein isothiocyanate dextran 40,000 ¤FD-40¥ were purchased from Sigma Chemical Co. ¤St. Louis, MO. USA¥. Anti-claudin antibodies were purchased from Zymed Laboratories, Inc. ¤CA, USA¥, and all secondary antibodies were purchased from BD Transduction Laboratories or BD Pharmingen ¤CA, USA¥. All other reagents were of analytical grade or better. Caco-2 cells, originating from a human colorectal carcinoma, were purchased from the American Type Culture Collection ¤Rockville, MD, USA¥. Dulbeccoös minimum essential medium ¤D-MEM¥ with L-glutamate, nonessential amino acids ¤NEAA, 100'¥, 0.05% trypsin-0.53 mM EDTA solution, and penicillin-streptomycin solution ¤100'¥ were obtained from Gibco Laboratories ¤Grand Island, NY, USA¥. Fetal bovine serum ¤FBS¥ and Hankös balanced salt solution ¤HBSS¥ were obtained from Sigma Chemical Co. ¤St. Louis, MO, USA¥.
Cell culture: Stock cultures of Caco-2 cells were maintained in D-MEM supplemented with 10% FBS, 10 mM HEPES, 50 units/mL penicillin, and 50 µg/mL streptomycin, as described previously. 28¥ The complete medium consisted of D-MEM supplemented with 10% FBS and 1% nonessential amino acids without antibiotics. The cells were grown in an atmosphere of 5% CO 2 /95% O 2 air at 37ôC and sub-cultured every week using 0.02% EDTA and 0.05% trypsin. The Caco-2 cells ¤passages 35®67¥ were seeded on polycarbonate membrane filters ¤0.4 µm pore size, 1 cm 2 growth area¥ in six-well flat-bottomed plates at a density of 1 ' 10 4 cells/well. Fresh complete medium was added every day, and the cells were used at 17 days or 18 days after seeding. The quantity of cellular protein and the cell number per well were determined.
Transport studies and transepithelial electrical resistance ¤TEER¥: Transport studies were conducted as described previously. 29¥ Cell monolayers were preincubated for 15 min at 37ôC in transport buffer solution ¤HBSS containing 25 mM D-glucose¥. Transport experiments were initiated by replacing the donor solution ¤apical compartment for absorptive transport, basal compartment for secretory transport¥ with 5 ml of transport buffer solution containing FD-40 or the model compounds in the presence of various concentrations of acylcarnitines ¤lauroylcarnitine or palmitoylcarnitine¥ in the apical compartment. The amount of FD-40 in the receiver compartment ¤basal compartment for absorptive transport, apical compartment for secretory transport¥ was evaluated as a function of time in the linear region of transport ¤under sink conditions on the donor side¥. To investigate the effects of inhibitors, cell monolayers were preincubated for 15 min at 37ôC with transport buffer solution in the presence or absence of TEA as an inhibitor of organic cation transporters or sodium azide Scheme 1. Structure of acylcarnitines a) Lauroylcarnitine, b) Palmitoylcarnitine as an energy depleting agent. The apical buffer solution was replaced with 5 ml of transport buffer solution containing the model compounds and various inhibitors. All experiments were conducted at pH 6.5 in the apical compartment and pH 7.4 in the basal compartment.
Transepithelial electrical resistance ¤TEER¥ was measured by mounting the cell monolayers, together with the polycarbonate filter, in diffusion chambers. The TEER used for the transport study was 600 to 750 Å&cm 2 in the absence of any paracellular permeation enhancer. TEER was calculated from the membrane potential difference ¤PD¥ measured under the load of a small external current ¤0.1 mA and 0.01 mA¥ according to Ohmös law using a short circuit current amplifier 29¥ ¤CEZ-9100, Nihon Koden, Japan¥. Quantitative analysis of FD-40: Samples were centrifuged at 10,000 rpm for 10 min, and the supernatant was analyzed using a fluorescence spectrophotometer at an excitation wavelength of 495 nm and an emission wavelength of 520 nm ¤Hitachi, FP6500, Tokyo, Japan¥.
Estimation of the permeation clearance of FD-40 across Caco-2 cell monolayers: Permeation clearance was obtained as follows:
where dQ/dt is the permeation flux, i.e., the transport rate ¤µg/min¥, and corresponds to the slope of the regression line, and C 0 is the initial concentration on the donor side ¤µg/mL¥. Clearance was obtained per unit surface area and expressed as nL/min/cm 2 . Determination of the claudin protein level using Western blot analysis: A crude membrane fraction was prepared from Caco-2 cells in a flask. Caco-2 cells were collected using a cell scraper ¤9000-220, Iwaki¥ and then homogenized in a storage buffer containing 19 mM KH 2 PO 4 , 81 mM K 2 HPO 4 , 1 mM EDTA-2Na, 1 mM dithiothreitol, 20% glycerol, 20 µM butylated hydroxytoluene ¤BHT¥, and 0.5 mM phenylmethylsulfonyl fluoride ¤PMSF¥ using a sonication homogenizer. The claudins in the detergentsolubilized samples were detected by Western blot analysis. For the samples solubilized with the detergent, we determined the protein amount by the Lowry method and loaded an equal protein amount into each well. The calibration curve for the total protein was used in the concentration range of 2.5 to 50 µg/mL and the correlation coefficient of the calibration curve was higher than 0.997.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis ¤SDS-PAGE¥ was conducted in 5®20% ¤w/v¥ gradient polyacrylamide gel, and then the separated proteins were electrophoretically transferred onto polyvinylidene fluoride membranes, as described by Tsuji et al. 30¥ The membranes were blocked with milk protein-based BlockAce ¤Dainippon Pharmaceutical Co., Osaka, Japan¥ for 20 min with vigorous shaking, before being washed three times with phosphatebuffered saline containing 0.1% Tween 20 and incubated with appropriate antibodies overnight at 4ôC. After being washed, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies to detect the primary antibodies. Specific bands were detected using the ECplus. The bands were quantified with a CS Analyzer ¤ATTO, Tokyo, Japan¥.
Determination of cholesterol level:
31,32¥
To examine the leakage and cellular content of cholesterol, Caco-2 cells were washed twice with serum-free medium and incubated with lauroylcarnitine, palmitoylcarnitine, or methyl-Ç-CD in serum-free medium at 37ôC for 1 h, according to the previously described procedure. 31,32¥ Cells were then washed twice with serum-free medium and incubated in serum-containing growth medium at 37ôC for the incubation period. To measure the leakage and amount of cellular cholesterol, the apical compartment medium was collected, and then cell sheets were thoroughly washed with cold phosphate buffered saline ¤PBS¥ and lysed with 1ml of 1% ¤v/v¥ Triton X-100 for 20 min at room temperature. The cell lysates were passed through a 22G needle 20 times, and cholesterol was assayed using a cholesterol assay kit ¤Wako Pure Chemical Industries, Osaka, Japan¥.
Statistical analysis: Statistical analysis was performed using Dunnettös test with p g 0.05 considered statistically significant.
Results
Effects of acylcarnitines and methyl-Ç-CD on the barrier function of tight junctions: We first determined the changes in the TEER of Caco-2 cell monolayers after the addition of acylcarnitines ¤Fig. 1a and Fig. 2a¥ . The value of TEER was stable in the control group for 60 min after HBSS treatment, suggesting that the barrier function of tight junctions was sustained for 60 min. On the other hand, TEER decreased significantly within 5 min of the application of lauroylcarnitine or palmitoylcarnitine and continued to decrease for 60 min in a dosedependent fashion ¤20®100 µM¥ ¤Fig. 1a and Fig. 2a¥ .
To confirm the relationship between the TEER reduction and the increase in paracellular permeability, we measured FD-40 flux and calculated the permeation clearance across the monolayers ¤Fig. 1b and Fig. 2b¥ . The FD-40 flux of the control group without acylcarnitine treatment did not change. In contrast, treatment with lauroylcarnitine or palmitoylcarnitine increased the FD-40 flux in a dosedependent fashion ¤20®100 µM¥ from 15 min after their addition ¤Fig. 1b and Fig. 2b¥ . The permeation clearance induced by 20, 50, and 100 µM lauroylcarnitine also increased in accordance with the increase in the FD-40 flux from 4.19 + 0.52 to 4.91 + 0.51, 6.59 + 1.49, and 10.1 + 1.35 nL/min/cm 2 , respectively. The permeation clearances induced by 20, 50, and 100 µM palmitoylcarnitine were 7.10 + 1.14, 10.1 + 2.54, and 19.5 + 4.77 nL/min/cm 2 , respectively.
We also examined the effect of 20 and 100 mM methyl-Ç-CD on the barrier function of Caco-2 cell monolayers, and we found that the effect on TEER exhibited a biphasic pattern ¤Fig. 3a¥. TEER decreased at 5 min after the addition of methyl-Ç-CD and then plateaued before decreasing from 15 min after 100 mM methyl-Ç-CD treatment. However, the TEER in the 20 mM application group had returned to the control level by 45 min.
Together with the measurement of TEER, the effects of methyl-Ç-CD on FD-40 flux and permeation clearance across Caco-2 cell monolayers were measured. The FD-40 flux increased for up to 60 min after the addition of methyl-Ç-CD in a dose-dependent fashion ¤Fig. 3b¥. However, the flux increased gradually, which is consistent with the decrease in TEER observed at 5 min after treatment. The permeation clearance in the 20 and 100 mM application groups increased to 15.3 + 3.07 and 29.1 + 8.06 nL/min/ cm 2 , respectively, from the control value of 4.19 + 0.52 nL/min/cm 2 . Effects of acylcarnitines and methyl-Ç-CD on the concentrations of tight junction proteins: The opening of tight junctions is primarily dependent on the composition and organization of tight junction components, especially the components responsible for the barrier function such as claudin and occludin. Thus, we focused on the effect of incubating Caco-2 cell monolayers for 60 min with acylcarnitines on the concentrations of the various claudin subtypes within the cells ¤Table 1¥. Treatment with both acylcarnitines decreased the protein concentrations of claudins 1, 4, and 5. The decrease in the protein levels of claudins 1, 4, and 5 by lauroylcarnitine and The circles, triangles, squares, and diamonds represent the control and the 20, 50, and 100 µM application groups, respectively (n = 6-8 for each condition). *P < 0.05, **P < 0.01. Fig. 2 . Effects of palmitoylcarnitine on the TEER (a) and the FD-40 flux in the apical to basal direction (b) in Caco-2 cell monolayers The circles, triangles, squares, and diamonds represent the control and the 20, 50, and 100 µM application groups, respectively (n = 6-8 for each condition). *P < 0.05, **P < 0.01.
Fig. 3. Effects of methyl-¢-CD on the TEER (a) and the FD-40 flux in the apical to basal direction (b) in Caco-2 cell monolayers
The circles, triangles, and diamonds represent the control, 20 mM and 100 mM application groups, respectively (n = 6-8 for each condition). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control.
† P < 0.05, † † P < 0.01 compared with the methyl-¢-CD 20 mM application group.
palmitoylcarnitine at 20 and 50 µM was not significantly different from the control levels, but a decreasing tendency could be seen. At 100 µM, both acylcarnitines significantly decreased the protein levels of claudins 1, 4, and 5. The concentrations of these proteins in the membrane fraction dramatically decreased. Unlike claudins 1, 4, and 5, there were no significant differences in the concentrations of claudins 2, 3, 6, or 7 in the lauroylcarnitine treatment group ¤Table 1¥. Also, palmitoylcarnitine at 100 µM affected the concentrations of claudins 3 and 7 in addition to those of claudins 1, 4, and 5. On the other hand, for claudin 2, concentration-dependent increasing effects of palmitoylcarnitine were found. Claudin 6 was not changed by acylcarnitines ¤Table 1¥.
We further examined the changes in the concentrations of tight junction proteins induced by incubating Caco-2 cell monolayers with methyl-Ç-CD at 20 and 100 mM for 60 min ¤Table 2¥. Decreases were found in the concentrations of claudins 4 and 5.
The recovery of the tight junction protein levels was examined 3 h after the Caco-2 cell monolayers had been washed and the medium had been replaced with fresh medium. As also shown by Western blot, the protein levels of all claudins that were affected by lauroylcarnitine and palmitoylcarnitine returned to the control levels, except for those of claudin 5 in the palmitoylcarnitine group ¤Fig. 4¥.
Effects of acylcarnitines and methyl-Ç-CD on the cholesterol in Caco-2 cell monolayers: We finally examined the effect of cholesterol depletion by acylcarnitine and methyl-Ç-CD treatment. As shown in Figures 5 and 6 , cholesterol leakage into the apical compartment was significantly increased in a dose-dependent fashion after Caco-2 cell monolayers had been treated for 60 min with 20®100 µM palmitoylcarnitine ¤Fig. 5¥. No such marked changes were found in the lauroylcarnitine group, except at 100 µM ¤Fig. 5¥. Twenty and 100 mM methyl-Ç-CD had significant effects on cholesterol leakage ¤Fig. 6¥.
Discussion
In the present study, we employed Caco-2 cell monolayers to examine the relationships between acylcarnitineinduced tight junction opening and the roles of claudin and cholesterol. Since Caco-2 cell monolayers express multiple claudin types, they are widely used for the study of tight junctions.
The barrier function of tight junctions was investigated by measuring TEER and FD-40 flux. Methyl-Ç-CD has previously been reported to open tight junctions in Caco-2 cell monolayers. 31¥ The concentration of acylcarnitines used in this study ¤up to 100 µM¥ was 10 3 times lower than that of methyl-Ç-CD ¤up to 100 mM¥. It is important that the effective concentration of acylcarnitines for enhancing drug absorption is much lower ¤about 1,000 times¥ than that of methyl-Ç-CD. Acylcarnitines can be considered promising safe and practical potential absorption enhancers.
Incubation with lauroylcarnitine or palmitoylcarnitine produced a dose-dependent decrease in TEER starting 5 min after treatment ¤Fig. 1a and Fig. 2a¥ . These changes in TEER were reflected by an increase in the permeability of the paracellular pathway within 15 min of the addition of the acylcarnitines ¤Fig. 1b and Fig. 2b¥ , indicating that both acylcarnitines are able to reduce the barrier function of tight junctions. Treatment with methyl-Ç-CD had similar effects Data are the mean percentage of the control and S.E. ¤n © 3 for each condition¥. *P g 0.05, **P g 0.01 compared with the control. Results represent the mean percentage of the control and S.E. ¤n © 3 for each condition¥. *P g 0.05, **P g 0.01 compared with the control.
to acylcarnitine treatment, except for the differences in concentration ¤Fig. 3¥. In normal conditions, the number of tight junction strands of a monolayer remains constant. When there is disordered partitioning of tight junction particles and tight junction strand components, the TEER changes. A high concentration of FD-40 on the donor side was used to enhance the detection sensitivity of the permeated FD-40 on the acceptor side; thereby, even in the absence of acylcarnitines, the flux of FD-40 was detectable ¤Figs. 1®3¥.
Since methyl-Ç-CD has been reported to open tight junctions by decreasing the number of strands they 
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Claudin-1 Claudin-2 Claudin-3 Claudin-4 Claudin-5 Claudin-6 Claudin-7 Fig. 4 . Recoveries of claudin protein expression levels after washout of the acylcarnitines Lauroylcarnitine (a) or palmitoylcarnitine (b) was incubated with Caco-2 cell monolayers for 1 h (open columns). The incubation medium was then replaced with fresh medium, and 3 h after that the expression levels of claudin proteins were determined (solid columns). The acylcarnitine concentration used in this study was 100 µM. Results are shown as the mean percentage of the control and the S.E. (n = 5-6 for each independent experiments). N.S., not significant, *P < 0.05 and **P < 0.01 compared with the value of the control group not treated with acylcarnitines. † † P < 0.01 compared with the 3 h value of the control group not treated with palmitoylcarnitine.
contain, 31¥ there is a similarity between the effects of acylcarnitines and methyl-Ç-CD on tight junctions. Differences were observed in the concentration-dependent effects of palmitoylcarnitine between the protein levels of claudins in Table 1 and cholesterol leakage in Figure 5 . These differences are likely due to the difference in detection sensitivity between protein levels and leaked cholesterol. However, it is clear that palmitoylcarnitine at the µM level has significant effects similar to those of methyl-Ç-CD at mM concentrations.
We further examined the distribution of tight junction proteins in the plasma membrane by solubilization using Triton X-100 as a nonionic detergent. The acylcarnitines were applied at concentrations of 20, 50, and 100 µM for 60 min to produce tight junction opening and the changes in protein levels of claudins 1®7 were measured ¤Table 1¥. As a common effect of both lauroylcarnitine and palmitoylcarnitine at 100 µM, a significant decrease in the protein levels of claudins 1, 4, and 5 was found, suggesting that these claudin proteins play important roles in the intestinal barrier function. For claudin 1, changes in protein level and concomitant changes in paracellular transport have often been reported, suggesting that claudin 1 is one of the regulating factors of the tight junction.
33,34¥ Also, claudin 4 plays an important role as a regulating protein of the tight junction, since there is a high correlation between the protein level of claudin 4 and the permeation clearance of paracellular marker FD-40 ¤data not shown¥. Claudin 5 is known as an important adhering factor in tight junctions. The roles of claudins 3 and 7 in the intestinal barrier function have been already reported, but only palmitoylcarnitine affected the levels of these two proteins.
For claudin 2, the protein level has been reported to increase in intestinal bowel disease. 35¥ A concentrationdependent increase in claudin 2 protein levels on palmitoylcarnitine treatment was observed around the critical micellar concentration of palmitoylcarnitine. Claudin 6 is reported to be related to the percutaneous barrier but not to the intestinal barrier. These phenomena remain topics for further investigation.
To elucidate the mechanisms of the effects of acylcarnitines on the concentrations of tight junction proteins, incubation with 20 or 100 mM methyl-Ç-CD for 60 min was used to disrupt lipid rafts. 36¥ Under control conditions, the tight junction proteins claudins 1®7 were found, and they demonstrated the normal concentrations in Caco-2 cell membranes. After the addition of methyl-Ç-CD, the distribution of tight junction proteins decreased significantly ¤Table 2¥. In a previous study, incubation with methyl-Ç-CD induced the displacement of claudins 3 and 4 and occludin from lipid rafts contained in the insoluble fraction of Caco-2 cell monolayers.
36,37¥ In the present study, the effects of methyl-Ç-CD on the concentrations of tight junction proteins varied from protein to protein; stronger effects tended to be observed for claudins 4 and 5 at 20 mM and for claudins 4 and 5 at 100 mM than for other proteins ¤Table 2¥. In particular, claudins 4 and 5 can be considered to be associated with cholesterol leakage ¤Fig. 6¥.
To summarize the effects of acylcarnitine treatment, claudins 4 and 5 were considered to be removed from the plasma membrane. The protein level of claudin 1 was decreased by treatment with 100 mM methyl-Ç-CD, and a similar change was also induced by treatment with 100 µM palmitoylcarnitine ¤Table 1¥. From these results, it can be considered that palmitoylcarnitine and methyl-Ç-CD produce their effects on the protein levels of claudins and tight junction function via similar action mechanisms. Fig. 5 . Effects of acylcarnitines on the leakage of cholesterol into the apical compartment in Caco-2 cell monolayers Lauroylcarnitine (LC) or palmitoylcarnitine (PC) was incubated with Caco-2 cell monolayers for 1 h. The apical side incubation medium was collected and the cholesterol levels were determined. The white, gray, black, and shaded columns represent 10, 20, 50, and 100 µM of acylcarnitine, respectively. Results are shown as means and S.E. (n = 5-6 for each condition). *P < 0.05, **P < 0.01 compared with the no additive group, i.e., the control group that was not treated with acylcarnitines. 6 . Effects of methyl-¢-CD on the leakage of cholesterol into the apical compartment in Caco-2 cell monolayers Methyl-¢-CD was incubated with Caco-2 cell monolayers for 1 h. The apical side incubation medium was collected and the cholesterol levels were determined. The white, gray, and black columns represent the no additive group and 20 and 100 mM methyl-¢-CD, respectively. Results are shown as means and S.E. (n = 3 for each condition). *P < 0.05, **P < 0.01.
In the present study, we examined the relationship between cholesterol depletion and the expression profiles of claudins in Caco-2 cell monolayers in the presence of methyl-Ç-CD. Since methyl-Ç-CD is able to efficiently extract cholesterol from the plasma membrane in a concentration-dependent fashion, cholesterol must influence the claudin 4 and 5 expression induced by methyl-Ç-CD. The leakage of cholesterol induced by methyl-Ç-CD treatment was similar to that induced by palmitoylcarnitine ¤Figs. 5 and 6¥, suggesting that methyl-Ç-CD and palmitoylcarnitine open tight junctions via similar action mechanisms. However, our data did not show a significant influence of lauroylcarnitine treatment on the leakage of cholesterol ¤Fig. 5¥. Lauroylcarnitine decreased the levels of claudins 1, 4, and 5 without causing cholesterol leakage. Since the effects of lauroylcarnitine and palmitoylcarnitine on cholesterol are obviously different, this fact should be further investigated.
The restoration of barrier function by the replenishment of tight junction proteins in plasma membranes indicates that the effects of acylcarnitines on barrier function are reversible ¤Fig. 4¥. These observations suggest a close relationship between the barrier function of tight junctions and cholesterol ¤Fig. 5¥.
In conclusion, our results demonstrate that the effects of palmitoylcarnitine and methyl-Ç-CD on tight junction proteins may be mediated by the specific disruption of claudins 4 and 5. Our findings offer a profound insight into the detailed mechanism of the effects of palmitoylcarnitine on tight junction proteins.
